Machine Learning in Drug Discovery Symposium: Closing Remarks @broadinstitute
Machine Learning in Drug Discovery Symposium: Closing Remarks  @broadinstitute
Uploaded January 2026 | Updated September 2026, 2 weeks ago
Closing Remarks

The Machine Learning in Drug Discovery Symposium was held on November 7, 2025 at the Broad Institute.

This hybrid symposium highlights recent progress in the application of machine learning techniques to drug discovery and brings together researchers working in applying machine learning to target validation, hit identification and optimization, clinical trial design, biologics, and other areas of drug discovery for talks, poster sessions and networking.

For questions about the symposium or interest in sponsoring the 2026 symposium, reach out to mlinddsymposium@broadinstitute.org.

For more information, visit: broadinstitute.org/machine-learning-drug-discovery-symposium/machine-learning-drug-discovery

Copyright Broad Institute, 2025. All rights reserved.
Machine Learning in Drug Discovery Symposium: Closing RemarksML4H: E. Oikonomou/R. Khera, Personalized Inference from Randomized Clinical Trials to Real CareMPG Primer: Local ancestry inference (LAI) (2026)MPG Primer: Genotype, Phenotype, and GWAS Data (2026)ML4H: Milos Vukadinovic, Vision-language Foundation Models for Cardiac ImagingMachine Learning in Drug Discovery: Oren Kraus11th Annual Rare Disease Day Event: Scientific Keynote, Mandana ArbabThree Impactful problems in drug discovery that might be solvable with machine learningMIA Primer: Jacob Blindenbach, Ultra-secure computing with homomorphic encryption for genome privacyMPG Primer: DNA sequencing with the Blended Genome Exome (2025)11th Annual Rare Disease Day Event: Juliana GentileObesity ML Competition: Lecture 2, Part C - Tech - Measuring Perturbation Effects in Cells
Broad Institute |

Machine Learning in Drug Discovery Symposium: Closing Remarks

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER